Executive Director Elizabeth Estes, Melissa Leichter of Novo Nordisk, and Panna Sharma of Lantern Pharma Inc. discussed the potential of using AI and machine learning to treat rare diseases.
Rare Disease Summit Summit 2024
Get the latest OSIC news delivered right to your inbox.
No spam. Just news.
Copyright © 2025 Open Source Consortium (OSIC). All Rights Reserved.